|
1
|
Kudo K, Gavin E, Das S, Amable L, Shevde
LA and Reed E: Inhibition of Gli1 results in altered c-Jun
activation, inhibition of cisplatin-induced upregulation of ERCC1,
XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
Oncogene. 31:4718–4724. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steg AD, Bevis KS, Katre AA, et al: Stem
cell pathways contribute to clinical chemoresistance in ovarian
cancer. Clin Cancer Res. 18:869–881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ulasov IV, Nandi S, Dey M, Sonabend AM and
Lesniak MS: Inhibition of Sonic hedgehog and Notch pathways
enhances sensitivity of CD133+glioma stem cells to
temozolomide therapy. Mol Med. 17:103–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reed E: Cisplatin, carboplatin and
oxaliplatin. Cancer Chemotherapy and Biotherapy: Principles and
Practice. 4th edition. Chabner BA and Longo DL: Lippincott Williams
and Wilkins; Philadelphia: pp. 332–343. 2006
|
|
5
|
Parker RJ, Eastman A, Bostick-Bruton F and
Reed E: Acquired cisplatin resistance in human ovarian cancer cells
is associated with enhanced repair of cisplatin-DNA lesions and
reduced drug accumulation. J Clin Invest. 87:772–777. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reed E: Cisplatin and platinum analogs.
Cancer Principles and Practice of Oncology. 8th edition. DeVita VT,
Rosenberg SA and Lawrence T: Lippincott Williams and Wilkins;
Philadelphia: pp. 419–426. 2008
|
|
7
|
Reed E and Chabner BA: Platinum analogues.
Cancer Chemotherapy and Biotherapy: Principles and Practice. 5th
edition. Chabner BA and Longo DL: Lippincott Williams and Wilkins;
Philadelphia: pp. 310–322. 2011
|
|
8
|
Hall MD, Okabe M, Shen DW, Liang XJ and
Gottesman MM: The role of cellular accumulation in determining
sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol
Toxicol. 48:495–535. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reed E, Sauerhoff S and Poirier MC:
Quantitation of platinum-DNA binding in human tissues following
therapeutic levels of drug exposure: a novel use of graphite
furnace spectrometry. Atomic Spectroscopy. 9:93–95. 1988.
|
|
10
|
Laner-Plamberger S, Kaser A, Paulischta M,
Hauser-Kronberger C, Eichberger T and Frischauf AM: Cooperation
between GLI and JUN enhances transcription of JUN and selected GLI
target genes. Oncogene. 28:1639–1651. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu H and Lo HW: The human
glioma-associated oncogene homolog 1 (GLI1) family of transcription
factors in gene regulation and diseases. Curr Genomics. 11:238–245.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hess J, Angel P and Schorpp-Kistner M:
AP-1 subunits: quarrel and harmony among siblings. J Cell Sci.
117:5965–5973. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stein B, Angel P, van Dam H, et al:
Ultraviolet-radiation induced c-jun gene transcription: two AP-1
like binding sites mediate the response. Photochem Photobiol.
55:409–415. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee KB, Parker RJ, Bohr V, Cornelison T
and Reed E: Cisplatin sensitivity/resistance in UV repair-deficient
Chinese hamster ovary cells of complementation groups 1 and 3.
Carcinogenesis. 14:2177–2180. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Richon VM, Schulte N and Eastman A:
Multiple mechanisms of resistance to
cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells.
Cancer Res. 47:2056–2061. 1987.PubMed/NCBI
|
|
16
|
Eastman A and Schulte N: Enhanced DNA
repair as a mechanism of resistance to
cis-diamminedichloroplatinum(II). Biochemistry. 27:4730–4734. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eastman A: Mechanisms of resistance to
cisplatin. Cancer Treat Res. 57:233–249. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reed E: Cisplatin. Cancer Chemotherapy and
Biological Response Modifiers. Pinedo H, Longo D and Chabner B:
Elsevier Science; Amsterdam: pp. 83–90. 1992
|
|
19
|
Dabholkar M, Parker R and Reed E:
Determinants of cisplatin sensitivity in non-malignant
non-drug-selected human T cell lines. Mutat Res. 274:45–56. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Masuda H, Ozols RF, Lai GM, Fojo A,
Rothenberg M and Hamilton TC: Increased DNA repair as a mechanism
of acquired resistance to cis-diamminedichloroplatinum (II) in
human ovarian cancer cell lines. Cancer Res. 48:5713–5716.
1988.PubMed/NCBI
|
|
21
|
Ferry KV, Hamilton TC and Johnson SW:
Increased nucleotide excision repair in cisplatin-resistant ovarian
cancer cells: role of ercc1-xpf. Biochem Pharmacol. 60:1305–1313.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Godwin AK, Meister A, O’Dwyer PJ, Huang
CS, Hamilton TC and Anderson ME: High resistance to cisplatin in
human ovarian cancer cell lines is associated with marked increase
of glutathione synthesis. Proc Natl Acad Sci USA. 89:3070–3074.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yao KS, Godwin AK, Johnson SW, Ozols RF,
O’Dwyer PJ and Hamilton TC: Evidence for altered regulation of
gamma-glutamylcysteine synthetase gene expression among
cisplatin-sensitive and cisplatin-resistant human ovarian cancer
cell lines. Cancer Res. 55:4367–4374. 1995.
|
|
24
|
Agyeman A, Mazumdar T and Houghton JA:
Regulation of DNA damage following termination of Hedgehog (HH)
survival signaling at the level of the GLI genes in human colon
cancer. Oncotarget. 3:854–868. 2012.PubMed/NCBI
|
|
25
|
Leonard JM, Ye H, Wetmore C and Karnitz
LM: Sonic Hedgehog signaling impairs ionizing radiation-induced
checkpoint activation and induces genomic instability. J Cell Biol.
183:385–391. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mazumdar T, Devecchio J, Agyeman A, Shi T
and Houghton JA: Blocking Hedgehog survival signaling at the level
of the GLI genes induces DNA damage and extensive cell death in
human colon carcinoma cells. Cancer Res. 71:5904–5914. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mazumdar T, DeVecchio J, Agyeman A, Shi T
and Houghton JA: The GLI genes as the molecular switch in
disrupting Hedgehog signaling in colon cancer. Oncotarget.
2:638–645. 2011.PubMed/NCBI
|
|
28
|
Amable L, Gavin E, Kudo K, et al: Gli1
upregulates c-jun through a specific 130 kDa isoform. Int J Oncol.
(In press).
|
|
29
|
Martins V, Hanana M, Blumwald E and Geros
H: Copper transport and compartmentation in grape cells. Plant Cell
Physiol. 53:1866–1880. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takahashi R, Bashir K, Ishimaru Y,
Nishizawa NK and Nakanishi H: The role of heavy-metal ATPases,
HMAs, in zinc and cadmium transport in rice. Plant Signal Behav.
7:1605–1607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mikkelsen MD, Pedas P, Schiller M, et al:
Barley HvHMA1 is a heavy metal pump involved in mobilizing
organellar Zn and Cu and plays a role in metal loading into grains.
PLoS One. 7:e490272012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Q, Gardner K, Zhang L, Tsang B,
Bostick-Bruton F and Reed E: Cisplatin induction of ERCC-1 mRNA
expression in A2780/CP70 human ovarian cancer cells. J Biol Chem.
273:23419–23425. 1998. View Article : Google Scholar : PubMed/NCBI
|
